Announcements Trials

Browse Landscape

Phase

Phase 2 8 Phase 1 3 Phase 4 1 Phase 3 1

Status

Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, B-Cell 1

Interventions

Propofol 9 Sevoflurane 7 Rituximab 7 Magnetic Resonance Spectroscopy 6 Dexamethasone 6 Trastuzumab 5 Specimen Handling 5 Enoxaparin 5 Carboplatin 5 Bevacizumab 5 Nivolumab 4 Capecitabine 4 Bupivacaine 4 trametinib 3 pirtobrutinib 3 dabrafenib 3 atezolizumab 3 apixaban 3 Lenalidomide 3 Indocyanine Green 3 Gemcitabine 3 Docetaxel 3 Cyclophosphamide 3 zanubrutinib 2 venetoclax 2 trastuzumab deruxtecan 2 ribociclib 2 polyethylene glycol 3350 2 pertuzumab 2 pembrolizumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Recruiting × axicabtagene ciloleucel × Clear all

NCT06609304 2024-10-15

axi-cel

Zhengzhou University

Phase 4 Recruiting

Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡